Hexahydrocannabinol (HHC) use and harms in Ireland: New findings from the 2024 European Web Survey on Drugs.
Saved in:
| Title: | Hexahydrocannabinol (HHC) use and harms in Ireland: New findings from the 2024 European Web Survey on Drugs. |
|---|---|
| Authors: | Mongan D; Health Research Board, Dublin, Ireland. Electronic address: dmongan@hrb.ie., Killeen N; Health Service Executive National Social Inclusion Office, Dublin, Ireland. Electronic address: Nicki.Killeen@hse.ie., Millar SR; Health Research Board, Dublin, Ireland; School of Public Health, University College Cork, Cork, Ireland. Electronic address: s.millar@ucc.ie., Matias J; European Union Drugs Agency, Lisbon, Portugal. Electronic address: joao.matias@euda.europa.eu., Keenan E; Health Service Executive National Social Inclusion Office, Dublin, Ireland. Electronic address: eamon.keenan@hse.ie., Galvin B; Health Research Board, Dublin, Ireland. Electronic address: bgalvin@hrb.ie. |
| Source: | The International journal on drug policy [Int J Drug Policy] 2025 Nov; Vol. 145, pp. 105011. Date of Electronic Publication: 2025 Sep 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9014759 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4758 (Electronic) Linking ISSN: 09553959 NLM ISO Abbreviation: Int J Drug Policy Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
